Impact Biomedical IBO
NYSE IBO
$5.46 -0.14 (-2.50%)
As of: Oct 1, 2026 · 3:57 PM EDT

Impact Biomedical (IBO) Operating Expenses (2022 - 2026)

Updated

Impact Biomedical (IBO) recorded Operating Expenses of $705,000 in Q2 2026, down 39.2% from $1.16 million a year earlier and down 69.3% from the prior quarter.

Analysis

Impact Biomedical (IBO) Operating Expenses (2022 - 2026) Analysis & Trends

On a TTM basis, Impact Biomedical's Operating Expenses came in at $3.53 million as of Jun 30, 2026, down 88.1% year-over-year; for FY2025, it came in at $318,000, down 98.9% from FY2024.

  • Annual Operating Expenses has a three-year compound annual growth rate of -54.8% (FY2022 to FY2025).
  • Across earlier years, Operating Expenses came in at $28.75 million in FY2024 (+613.8%), $4.03 million in FY2023 (+16.6%) and $3.45 million in FY2022.
  • Quarterly Operating Expenses has ranged from -$441,000 in Q4 2025 to $26.23 million in Q4 2024 over the past five years.
  • On a year-over-year basis, Operating Expenses rose in four of the last six quarters, with growth averaging 32.4%.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 127.3% in Q1 2026, against a decline of 39.2% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.3 million (Q1 2026), -$441,000 (Q4 2025) and $966,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Impact Biomedical 598.41 Mn 601.61 Mn 2,000.00 705,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 705,000.00
Mar 31, 2026 2.30 Mn
Dec 31, 2025 -441,000.00
Sep 30, 2025 966,000.00
Jun 30, 2025 1.16 Mn
Mar 31, 2025 1.01 Mn
Dec 31, 2024 26.23 Mn
Sep 30, 2024 1.13 Mn
Jun 30, 2024 626,000.00
Mar 31, 2024 771,000.00
Dec 31, 2023 1.14 Mn
Sep 30, 2023 1.08 Mn
Jun 30, 2023 1.01 Mn
Mar 31, 2023 803,000.00
Dec 31, 2022 1.03 Mn
Sep 30, 2022 889,000.00
Jun 30, 2022 800,000.00
API Access

Impact Biomedical Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=IBO&period=max&api_key=YOUR_API_KEY